Does Breast-Conserving Surgery with Radiotherapy Have a Better Survival Than Mastectomy? A Meta-Analysis of More Than 1,500,000 Patients

Overview

Journal Ann Surg Oncol

Publisher Springer

Specialty Oncology

Date 2022 Jul 25

PMID 35876923

Authors

Gabriel De la Cruz Ku

Manish Karamchandani

Diego Chambergo-Michilot

Alexis R Narvaez-Rojas

Michael Jonczyk

Fortunato S Principe-Meneses

David Posawatz

Salvatore Nardello

Abhishek Chatterjee

Affiliations

Soon will be listed here.

Abstract

Background: There have been conflicting studies reporting on survival advantages between breast-conserving surgery with radiotherapy (BCS) in comparison with mastectomy. Our aim was to compare the efficacy of BCS and mastectomy in terms of overall survival (OS) comparing all past published studies.

Methods: We performed a comprehensive review of literature through October 2021 in PubMed, Scopus, and EMBASE. The studies included were randomized controlled trials (RCTs) and cohorts that compare BCS versus mastectomy. We excluded studies that included male sex, stage 0, distant metastasis at diagnosis, bilateral synchronous cancer, neoadjuvant radiation/chemotherapy, and articles with incomplete data. We performed a meta-analysis following the random-effect model with the inverse variance method.

Results: From 18,997 publications, a total of 30 studies were included in the final analysis: 6 studies were randomized trials, and 24 were retrospective cohorts. A total of 1,802,128 patients with a follow-up ranging from 4 to 20 years were included, and 1,075,563 and 744,565 underwent BCS and mastectomy, respectively. Among the population, BCS is associated with improved OS compared with mastectomy [relative risk (RR) 0.64, 95% confidence interval (CI) 0.55-0.74]. This effect was similar when analysis was performed in cohorts and multi-institutional databases (RR 0.57, 95% CI 0.49-0.67). Furthermore, the benefit of BCS was stronger in patients who had less than 10 years of follow-up (RR 0.54, 95% CI 0.46-0.64).

Conclusions: Patients who underwent BCS had better OS compared with mastectomy. Such results depicting survival advantage, especially using such a large sample of patients, may need to be included in the shared surgical decision making when discussing breast cancer treatment with patients.

Citing Articles

Superior Survival and Lower Recurrence Outcomes with Breast-Conserving Surgery Compared to Mastectomy Following Neoadjuvant Therapy in 607 Breast Cancer Patients.

Gentile D, Canzian J, Barbieri E, Di Maria Grimaldi S, De Sanctis R, Tinterri C Cancers (Basel). 2025; 17(5).

PMID: 40075614 PMC: 11899183. DOI: 10.3390/cancers17050766.

Comparison of Survival Outcomes of Breast-Conserving Surgery Plus Radiotherapy with Mastectomy in Early Breast Cancer Patients: Less Is More?.

Duangkaew C, Somwangprasert A, Watcharachan K, Wongmaneerung P, Ko-Iam W, Kaweewan I Cancers (Basel). 2025; 17(4).

PMID: 40002186 PMC: 11852543. DOI: 10.3390/cancers17040591.

Locoregional Lymph Node Metastasis from Clinically Occult Breast Cancer: Prognostic Significance of Mastectomy.

Naerum A, Holm-Rasmussen E, Vejborg I, Knoop A, Laenkholm A, Kroman N Breast J. 2025; 2024:5878308.

PMID: 39742355 PMC: 11329309. DOI: 10.1155/2024/5878308.

Clinical and patient-reported outcomes in women offered oncoplastic breast-conserving surgery as an alternative to mastectomy: ANTHEM multicentre prospective cohort study.

Davies C, Johnson L, Conefrey C, Mills N, Fairbrother P, Holcombe C Br J Surg. 2024; 112(1).

PMID: 39718969 PMC: 11668256. DOI: 10.1093/bjs/znae306.

Role of Immunotherapy in Conjunction With the Surgical Treatment of Breast Cancer: Preoperative and Postoperative Applications.

Sabu N, Attia Hussein Mahmoud H, Salazar Gonzalez J, Naruboina N, Esteban Rojas Prieto S, Govender S Cureus. 2024; 16(10):e71441.

PMID: 39539894 PMC: 11559439. DOI: 10.7759/cureus.71441.

References

Gu J, Groot G, Boden C, Busch A, Holtslander L, Lim H . Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review. Clin Breast Cancer. 2018; 18(4):e539-e554. DOI: 10.1016/j.clbc.2017.12.013. View

Arndt V, Stegmaier C, Ziegler H, Brenner H . Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study. J Cancer Res Clin Oncol. 2008; 134(12):1311-8. DOI: 10.1007/s00432-008-0418-y. View

van Maaren M, de Munck L, de Bock G, Jobsen J, van Dalen T, Linn S . 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol. 2016; 17(8):1158-1170. DOI: 10.1016/S1470-2045(16)30067-5. View

Landercasper J, Ramirez L, Borgert A, Ahmad H, Parsons B, Dietrich L . A Reappraisal of the Comparative Effectiveness of Lumpectomy Versus Mastectomy on Breast Cancer Survival: A Propensity Score-Matched Update From the National Cancer Data Base (NCDB). Clin Breast Cancer. 2019; 19(3):e481-e493. DOI: 10.1016/j.clbc.2019.02.006. View

Li H, Chen Y, Wang X, Tang L, Guan X . T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis. Clin Breast Cancer. 2019; 19(6):e669-e682. DOI: 10.1016/j.clbc.2019.05.011. View

Hartmann-Johnsen O, Karesen R, Schlichting E, Nygard J . Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008. Ann Surg Oncol. 2015; 22(12):3836-45. PMC: 4595537. DOI: 10.1245/s10434-015-4441-3. View

de Boniface J, Szulkin R, Johansson A . Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48 986 Women. JAMA Surg. 2021; 156(7):628-637. PMC: 8100916. DOI: 10.1001/jamasurg.2021.1438. View

Kim H, Lee S, Nam S, Lee E, Park B, Park H . Survival of Breast-Conserving Surgery Plus Radiotherapy versus Total Mastectomy in Early Breast Cancer. Ann Surg Oncol. 2021; 28(9):5039-5047. DOI: 10.1245/s10434-021-09591-x. View

Almahariq M, Quinn T, Siddiqui Z, Jawad M, Chen P, Gustafson G . Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer. Radiother Oncol. 2019; 142:186-194. DOI: 10.1016/j.radonc.2019.09.018. View

10.

Hofvind S, Holen A, Aas T, Roman M, Sebuodegard S, Akslen L . Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. Eur J Surg Oncol. 2015; 41(10):1417-22. DOI: 10.1016/j.ejso.2015.07.002. View

11.

Onitilo A, Engel J, Stankowski R, Doi S . Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy. Clin Med Res. 2014; 13(2):65-73. PMC: 4504664. DOI: 10.3121/cmr.2014.1245. View

12.

Mahmood U, Morris C, Neuner G, Koshy M, Kesmodel S, Buras R . Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012; 83(5):1387-93. DOI: 10.1016/j.ijrobp.2011.10.075. View

13.

Litiere S, Werutsky G, Fentiman I, Rutgers E, Christiaens M, Van Limbergen E . Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012; 13(4):412-9. DOI: 10.1016/S1470-2045(12)70042-6. View

14.

Blichert-Toft M, BRINCKER H, Andersen J, ANDERSEN K, Axelsson C, Mouridsen H . A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary results. Acta Oncol. 1988; 27(6A):671-7. DOI: 10.3109/02841868809091767. View

15.

Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A . Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347(16):1227-32. DOI: 10.1056/NEJMoa020989. View

16.

Fisher B, Anderson S, Bryant J, Margolese R, Deutsch M, Fisher E . Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347(16):1233-41. DOI: 10.1056/NEJMoa022152. View

17.

Simone N, Dan T, Shih J, Smith S, Sciuto L, Lita E . Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast Cancer Res Treat. 2011; 132(1):197-203. PMC: 8369835. DOI: 10.1007/s10549-011-1867-6. View

18.

van Dongen J, Voogd A, Fentiman I, LeGrand C, Sylvester R, Tong D . Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000; 92(14):1143-50. DOI: 10.1093/jnci/92.14.1143. View

19.

Lee H, Yoon D, Koo J, Suh C, Jung W, Oh K . Breast conserving therapy in stage I & II breast cancer in Korea. Breast Cancer Res Treat. 1997; 44(3):193-9. DOI: 10.1023/a:1005810432500. View

20.

Fentiman I, van Zijl J, Karydas I, Chaudary M, Margreiter R, LeGrand C . Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen. Eur J Cancer. 2003; 39(3):300-8. DOI: 10.1016/s0959-8049(02)00672-x. View